Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cardio Diagnostics Holdings Inc. - Common stock
(NQ:
CDIO
)
0.7344
+0.0139 (+1.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cardio Diagnostics Holdings Inc. - Common stock
< Previous
1
2
Next >
New Study Shows Cardio Diagnostics’ (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
May 07, 2024
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
April 29, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
April 09, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre
April 04, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
March 14, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
March 05, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout
February 15, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters
February 07, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
February 05, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
January 30, 2024
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Topics
Death
Exposures
Death
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
January 24, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
January 09, 2024
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
January 08, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™
January 04, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event
January 03, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
January 02, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors
December 21, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association
December 19, 2023
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement
December 06, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference
December 04, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
American Medical Association is Reviewing Cardio Diagnostics Holdings, Inc’s Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes
November 28, 2023
From
Cardio Diagnostics Holdings
Via
Business Wire
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.
November 20, 2023
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Topics
Death
Exposures
Death
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association
November 20, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
With New Lab/Operations Hub, Cardio Diagnostics Says it’s Prepared To Meet Uptake In Demand, Announces New Partner Initiative
November 14, 2023
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Family Medicine Specialists Selects Cardio Diagnostics’ Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients
November 07, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
October 31, 2023
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD
October 31, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India
October 17, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins
October 12, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics
September 20, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.